Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 539475, 8 pages
http://dx.doi.org/10.1155/2012/539475
Research Article

Effect of Cymbopogon citratus and Citral on Vascular Smooth Muscle of the Isolated Thoracic Rat Aorta

1Department of Physiology, Faculty of Medicine, University of Malaya, Lembah Pantai, 50603 Kuala Lumpur, Malaysia
2Department of Pharmacology, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia

Received 21 January 2012; Accepted 17 March 2012

Academic Editor: Guillermo Schmeda-Hirschmann

Copyright © 2012 R. Chitra Devi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. E. Simon, A. F. Chadwick, and L. E. Craker, Herbs: An Indexed Bibliography. 1971–1980. The Scientific Literature on Selected Herbs, and Aromatic and Medicinal Plants of the Temperate Zone, Archon Books, Boulder, Colo, USA, 1984.
  2. J. R. Leite, M. D. L. V. Seabra, and E. Maluf, “Pharmacology of lemongrass (Cymbopogon citratus Stapf). III. Assessment of eventual toxic, hypnotic and anxiolytic effects on humans,” Journal of Ethnopharmacology, vol. 17, no. 1, pp. 75–83, 1986. View at Google Scholar · View at Scopus
  3. R. C. Devi, S. M. Sim, and R. Ismail, “Spasmolytic effect of citral and extracts of Cymbopogon citratus on isolated rabbit ileum,” Journal of Smooth Muscle Research, vol. 47, no. 5, pp. 143–156, 2011. View at Google Scholar
  4. E. A. Carlini, J. D. D. P. Contar, and A. R. Silva-Filho, “Pharmacology of lemongrass (Cymbopogon citratus Stapf). I. Effects of teas prepared from the leaves on laboratory animals,” Journal of Ethnopharmacology, vol. 17, no. 1, pp. 37–64, 1986. View at Google Scholar · View at Scopus
  5. F. Borrelli and A. A. Izzo, “The plant kingdom as a source of anti-ulcer remedies,” Phytotheraphy Research, vol. 14, no. 8, pp. 581–591, 2000. View at Google Scholar
  6. J. Cheel, C. Theoduloz, J. Rodríguez, and G. Schmeda-Hirschmann, “Free radical scavengers and antioxidants from lemongrass (Cymbopogon citratus (DC.) Stapf),” Journal of Agricultural and Food Chemistry, vol. 53, no. 7, pp. 2511–2517, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. I. Runnie, M. N. Salleh, S. Mohamed, R. J. Head, and M. Y. Abeywardena, “Vasorelaxation induced by common edible tropical plant extracts in isolated rat aorta and mesenteric vascular bed,” Journal of Ethnopharmacology, vol. 92, no. 2-3, pp. 311–316, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Bakkali, S. Averbeck, D. Averbeck, and M. Idaomar, “Biological effects of essential oils—a review,” Food and Chemical Toxicology, vol. 46, no. 2, pp. 446–475, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. Z. Yang, J. Xi, J. Li, and W. Qu, “Biphasic effect of citral, a flavoring and scenting agent, on spatial learning and memory in rats,” Pharmacology Biochemistry and Behavior, vol. 93, no. 4, pp. 391–396, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. S. I. Rabbani, K. Devi, S. Khanam, and N. Zahra, “Citral, a component of lemongrass oil inhibits the clastogenic effect of nickel chloride in mouse micronucleus test system,” Pakistan Journal of Pharmaceutical Sciences, vol. 19, no. 2, pp. 108–113, 2006. View at Google Scholar · View at Scopus
  11. N. Dudai, Y. Weinstein, M. Krup, T. Rabinski, and R. Ofir, “Citral is a new inducer of caspase-3 in tumor cell lines,” Planta Medica, vol. 71, no. 5, pp. 484–488, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Tanaka, M. Funabiki, H. Michikawa, and K. Koike, “Effects of aging on α1-adrenoceptor mechanisms in the isolated mouse aortic preparation,” Journal of Smooth Muscle Research, vol. 42, no. 4, pp. 131–138, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. M. Pinto, M. Paul, and D. Ganten, “Lessons from rat models of hypertension: from Goldblatt to genetic engineering,” Cardiovascular Research, vol. 39, no. 1, pp. 77–88, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. C. H. Conrad, W. W. Brooks, J. A. Hayes, S. Sen, K. G. Robinson, and O. H. L. Bing, “Myocardial fibrosis and stiffness with hypertrophy and heart failure in the spontaneously hypertensive rat,” Circulation, vol. 91, no. 1, pp. 161–170, 1995. View at Google Scholar · View at Scopus
  15. K. Okamoto, “Development of a strain of spontaneously hypertensive rats,” Japanese Circulation Journal, vol. 27, pp. 282–293, 1963. View at Google Scholar · View at Scopus
  16. F. L. Rosenfeldt, G. W. He, B. F. Buxton, and J. A. Angus, “Pharmacology of coronary artery bypass grafts,” Annals of Thoracic Surgery, vol. 67, no. 3, pp. 878–888, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. R. J. Gonzales, D. N. Krause, and S. P. Duckles, “Testosterone suppresses endothelium-dependent dilation of rat middle cerebral arteries,” American Journal of Physiology, vol. 286, no. 2, pp. H552–H560, 2004. View at Google Scholar · View at Scopus
  18. A. K. Jain, Manual of Practical Physiology, Avichal Publishing, New Delhi, India, 2000.
  19. O. F. Carrasco and H. Vidrio, “Endothelium protectant and contractile effects of the antivaricose principle escin in rat aorta,” Vascular Pharmacology, vol. 47, no. 1, pp. 68–73, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Ajay, H. J. Chai, A. M. Mustafa, A. H. Gilani, and M. R. Mustafa, “Mechanisms of the anti-hypertensive effect of Hibiscus sabdariffa L. calyces,” Journal of Ethnopharmacology, vol. 109, no. 3, pp. 388–393, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. P. J. Houghton and A. Raman, Laboratory Handbook for the Fractionation of Natural Extracts, Chapman & Hall, New York, NY, USA, 1st edition, 1998.
  22. S. R. Ambrosio, C. R. Tirapelli, F. B. da Costa, and A. M. de Oliveira, “Kaurane and pimarane-type diterpenes from the Viguiera species inhibit vascular smooth muscle contractility,” Life Sciences, vol. 79, no. 10, pp. 925–933, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Godfraind, “EDRF and cyclic GMP control gating of receptor-operated calcium channels in vascular smooth muscle,” European Journal of Pharmacology, vol. 126, no. 3, pp. 341–343, 1986. View at Google Scholar · View at Scopus
  24. S. Moncada, R. M. J. Palmer, and E. A. Higgs, “Nitric oxide: physiology, pathophysiology, and pharmacology,” Pharmacological Reviews, vol. 43, no. 2, pp. 109–142, 1991. View at Google Scholar · View at Scopus
  25. D. Nunes Guedes, D. F. Silva, J. M. Barbosa-Filho, and I. Almeida De Medeiros, “Endothelium-dependent hypotensive and vasorelaxant effects of the essential oil from aerial parts of Mentha x villosa in rats,” Phytomedicine, vol. 11, no. 6, pp. 490–497, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Busse and I. Fleming, “Endothelial dysfunction in atherosclerosis,” Journal of Vascular Research, vol. 33, no. 3, pp. 181–194, 1996. View at Google Scholar · View at Scopus
  27. P. M. Vanhoutte and J. V. Mombouli, “Vascular endothelium: vasoactive mediators,” Progress in Cardiovascular Diseases, vol. 39, no. 3, pp. 229–238, 1996. View at Publisher · View at Google Scholar · View at Scopus
  28. T. F. Luscher and P. M. Vanhoutte, “Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat,” Hypertension, vol. 8, no. 4, pp. 344–348, 1986. View at Google Scholar · View at Scopus
  29. S. Moncada, “Prostaglandin endoperoxides and thromboxanes: formation and effects,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 297, supplement 1, pp. 81–84, 1977. View at Google Scholar · View at Scopus
  30. S. Moncada, A. G. Herman, E. A. Higgs, and J. R. Vane, “Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium,” Thrombosis Research, vol. 11, no. 3, pp. 323–344, 1977. View at Google Scholar · View at Scopus
  31. R. Paoletti and S. Govoni, “Classification of calcium antagonists: proposal of the WHO committee,” Pharmacological Research Communications, vol. 19, no. 3, pp. 195–208, 1987. View at Google Scholar · View at Scopus
  32. L. H. Fang, Y. M. Mu, L. L. Lin, P. G. Xiao, and G. H. Du, “Vasorelaxant effect of euxanthone in the rat thoracic aorta,” Vascular Pharmacology, vol. 45, no. 2, pp. 96–101, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Broekaert and T. Godfraind, “A comparison of the inhibitory effect of cinnarizine and papaverine on the noradrenaline- and calcium-evoked contraction of isolated rabbit aorta and mesenteric arteries,” European Journal of Pharmacology, vol. 53, no. 3, pp. 281–288, 1979. View at Google Scholar · View at Scopus